These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12552268)

  • 1. Type 1 diabetes: glycaemic control during adolescence.
    Lunt H; Kendall D; Moore MP; Owens N; Cole DR; Willis JA; Scott RS; Darlow BA
    N Z Med J; 2002 Dec; 115(1167):U282. PubMed ID: 12552268
    [No Abstract]   [Full Text] [Related]  

  • 2. Glycemic control and cardiovascular disease--should we reassess clinical goals?
    Cefalu WT
    N Engl J Med; 2005 Dec; 353(25):2707-9. PubMed ID: 16371637
    [No Abstract]   [Full Text] [Related]  

  • 3. Paediatric Diabetes Services--evidence that expanding the workforce allows intensification of insulin regimens and improves glycaemic control.
    Spinks JJ; Haest J; Ross K; London R; Edge JA
    Arch Dis Child; 2009 Aug; 94(8):646-7. PubMed ID: 19628885
    [No Abstract]   [Full Text] [Related]  

  • 4. In pursuit of lower A1c.
    Haller MJ; Silverstein JH
    J Pediatr; 2009 Aug; 155(2):161-2. PubMed ID: 19619746
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advantages of fast-acting insulin analogs: preprandial greater HbA1c lowering -- postprandial lower weight].
    MMW Fortschr Med; 2005 Aug; 147(33-34):45. PubMed ID: 16138637
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe autonomic neuropathy treated with subcutaneous insulin infusion.
    Prendergast JJ; Aubry W
    Diabetes Care; 1996 Jan; 19(1):90. PubMed ID: 8720543
    [No Abstract]   [Full Text] [Related]  

  • 7. [Self monitoring of blood glucose: tool for successful diabetes therapy].
    Hummel M
    MMW Fortschr Med; 2012 Nov; 154(20):65-8. PubMed ID: 23234124
    [No Abstract]   [Full Text] [Related]  

  • 8. Technology and Pregnancy.
    Yamamoto JM; Murphy HR
    Diabetes Technol Ther; 2018 Feb; 20(S1):S94-S103. PubMed ID: 29437483
    [No Abstract]   [Full Text] [Related]  

  • 9. Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK: Response to Roze et al.
    DeVries JH
    Diabet Med; 2006 Jun; 23(6):709; author reply 708. PubMed ID: 16759318
    [No Abstract]   [Full Text] [Related]  

  • 10. Six-Year Follow-Up After Insulin Pump Initiation: HbA1c Is Significantly Reduced Without Weight Gain.
    Andersen HU; Hangaard S; Hommel E; Ridderstråle M
    J Diabetes Sci Technol; 2018 Mar; 12(2):535-536. PubMed ID: 28927286
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe hypoglycemia, metabolic control, and diabetes management in young children with type 1 diabetes using insulin analogs--a follow-up report of a large multicenter database.
    Wagner VM; Rosenbauer J; Grabert M; Holl RW;
    Eur J Pediatr; 2008 Feb; 167(2):241-2. PubMed ID: 17377817
    [No Abstract]   [Full Text] [Related]  

  • 12. Bolus calculator settings in well-controlled type 1 diabetes patients (glycated hemoglobin < 7%) treated with insulin pumps.
    Matejko B; Grzanka M; Kieć-Wilk B; Małecki MT; Klupa T
    J Diabetes Sci Technol; 2013 May; 7(3):800-1. PubMed ID: 23759415
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with Lantus therapy in Swedish routine health care].
    Löndahl M; Nilsson A; Katzman P
    Lakartidningen; 2005 Sep 5-11; 102(36):2503, 2505. PubMed ID: 16196437
    [No Abstract]   [Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion in the treatment of children and adolescents with type 1 diabetes mellitus.
    Saha ME; Huuppone T; Mikael K; Juuti M; Komulainen J
    J Pediatr Endocrinol Metab; 2002; 15(7):1005-10. PubMed ID: 12199327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of continuous subcutaneous insulin infusion on glycaemic control in children and adolescents: a regional review in North East England using a bio-modelling approach.
    Sinha A; Thomas MF; Rushton SP; Cheetham T
    Diabet Med; 2012 Oct; 29(10):1342-3. PubMed ID: 22435852
    [No Abstract]   [Full Text] [Related]  

  • 16. Should the target A1C level be less than 7 percent? No: The case for modest glycemic control in patients with type 2 diabetes.
    Barry HC
    Am Fam Physician; 2012 Dec; 86(12):1-2. PubMed ID: 23316991
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin therapy during Ramadan fast for patients with type 1 diabetes mellitus.
    Azar ST; Khairallah WG; Merheb MT; Zantout MS; Fliti F
    J Med Liban; 2008; 56(1):46. PubMed ID: 19534091
    [No Abstract]   [Full Text] [Related]  

  • 18. Does A1c Have to Change for Hypoglycemia Reduction?
    Renard E
    Diabetes Technol Ther; 2015 Aug; 17(8):527-9. PubMed ID: 25978209
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased Usage of Insulin Pump Functions Not Associated With Improved HbA1c in Children and Adolescents With Type 1 Diabetes Mellitus.
    Sandberg H; Anderberg P; Forssell H; Ovhed I; Berglund J
    J Diabetes Sci Technol; 2016 Jul; 10(4):997-8. PubMed ID: 26721525
    [No Abstract]   [Full Text] [Related]  

  • 20. Nocturnal hypoglycemia in children with diabetes: an important problem revisited.
    Santiago JV
    J Pediatr; 1997 Jul; 131(1 Pt 1):2-4. PubMed ID: 9255180
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.